Healthcare & Life Sciences
MitrAssist
Israel
acquiredacquired
acquired
Stage
2
Investors
About
MitrAssist develops a minimally invasive cardiac implant that is placed on top of the heart's mitral valve to improve valve function and treat mitral regurgitation in patients who are not candidates for open-heart surgery.
Explore MitrAssist's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.